Geniposide Attenuates the Phosphorylation of Tau Protein in Cellular and Insulin‐deficient APP/PS1 Transgenic Mouse Model of Alzheimer's Disease

Ten years of protein kinase B signalling: a hard Akt to follow

Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · see citing works

Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

Hong, M., & Lee, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 533 · see citing works

Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes

Liu, Y. M., Liu, F., Grundke, I., Iqbal, K., & Gong, C. (2011) · The Journal of Pathology · doi:10.1002/path.2912 · Cited by 505 · see citing works

Glycogen synthase kinase 3: an emerging therapeutic target

Eldar-Finkelman, H. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02266-3 · Cited by 405 · see citing works

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

Grünblatt, E., Šalković‐Petrišić, M., Barilar, J. O., Riederer, P. F., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 376 · see citing works

Does insulin dysfunction play a role in Alzheimer's disease?

Gasparini, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02037-0 · Cited by 314 · see citing works

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

Reddy, P. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.052 · Cited by 300 · see citing works

Temporal memory deficits in Alzheimer’s mouse models: Rescue by genetic deletion of BACE1

Ohno, M., Chang, L., Tseng, W., Oakley, H., Citron, M., Klein, W. L., Vassar, R., & Disterhoft, J. F. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04551.x · Cited by 298 · see citing works

PI3-kinase/Akt/mTOR signaling: Impaired on/off switches in aging, cognitive decline and Alzheimer's disease

Neill, C. O. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.025 · Cited by 292 · see citing works

Defective insulin signaling pathway and increased GSK-3 activity in the brain of diabetic mice: parallels with Alzheimer’s disease and correction by insulin

Jolivalt, C. G., Lee, C. A., Beiswenger, K., Smith, J., Orlov, M., Torrance, M., & Masliah, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21787 · Cited by 281 · see citing works

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

Biessels, G. J., & Kappelle, L. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331041 · Cited by 266 · see citing works

Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications

Neumann, K., Rojo, L., Navarrete, L., Farias, G., Reyes, P., & Maccioni, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908919 · Cited by 236 · see citing works

Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis

Canu, N., Dus, L., Barbato, C., Ciotti, M. T., Brancolini, C., Rinaldi, A. M., Novak, M., Cattaneo, A., Bradbury, A., & Calissano, P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07061.1998 · Cited by 232 · see citing works

Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

Šalković‐Petrišić, M., Tribl, F., Schmidt, M., Hoyer, S., & Riederer, P. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03637.x · Cited by 223 · see citing works

The Neurite Retraction Induced by Lysophosphatidic Acid Increases Alzheimer's Disease-like Tau Phosphorylation

Sayas, C. L., Moreno-Flores, M. T., Ávila, J., & Wandosell, F. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37046 · Cited by 172 · see citing works

Synaptic Plasticity in the Hippocampus of a APP/PS1 Mouse Model of Alzheimer's Disease Is Impaired in Old but Not Young Mice

Gengler, S., Hamilton, A., & Hölscher, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009764 · Cited by 166 · see citing works

Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease

Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032792 · Cited by 155 · see citing works

Geniposide, a Novel Agonist for GLP-1 Receptor, Prevents PC12 Cells from Oxidative Damage via MAP Kinase Pathway

Liu, J., Yin, F., Zheng, X., Jing, J., & Hu, Y. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.021 · Cited by 145 · see citing works

Peripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo

Freude, S., Plum, L., Schnitker, J., Leeser, U., Udelhoven, M., Krone, W., Brüning, J. C., & Schubert, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3343 · Cited by 144 · see citing works

Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK 3β Pathway in Streptozotocin‐Induced A lzheimer Rat Model

Gao, C., Liu, Y., Jiang, Y., Ding, J., & Li, L. (2013) · Brain Pathology · doi:10.1111/bpa.12116 · Cited by 141 · see citing works

Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis

Ma, T., Huang, C., Zong, G., Zha, D., Meng, X., Li, J., & Tang, W. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01256.x · Cited by 107 · see citing works

Geniposide Plays an Anti-inflammatory Role via Regulating TLR4 and Downstream Signaling Pathways in Lipopolysaccharide-Induced Mastitis in Mice

Song, X., Zhang, W., Wang, T., Jiang, H., Zhang, Z., Fu, Y., Yang, Z., Cao, Y., & Zhang, N. (2014) · Inflammation · doi:10.1007/s10753-014-9885-2 · Cited by 103 · see citing works

Preventive Effect of Geniposide on Metabolic Disease Status in Spontaneously Obese Type 2 Diabetic Mice and Free Fatty Acid-Treated HepG2 Cells

Kojima, K., Shimada, T., Nagareda, Y., Watanabe, M., Ishizaki, J., Sai, Y., Miyamoto, K., & Aburada, M. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1613 · Cited by 101 · see citing works

Failures to reconsolidate memory in a mouse model of Alzheimer’s disease

Ohno, M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.05.001 · Cited by 95 · see citing works

Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3β-dependent Phosphorylation of Tau

Meske, V., Albert, F., & Ohm, T. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704292200 · Cited by 94 · see citing works

The Neuroprotection of Liraglutide on Alzheimer-Like Learning and Memory Impairment by Modulating the Hyperphosphorylation of Tau and Neurofilament Proteins and Insulin Signaling Pathways in Mice

Xiong, H., Chen, Z., Wang, J., Song, J., Zhao, G., Shen, H., & Deng, Y. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130584 · Cited by 90 · see citing works

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice

Hiltunen, M. O., Khandelwal, V. K. M., Yaluri, N., Tiilikainen, T., Tusa, M., Koivisto, H., Krzisch, M., Vepsäläinen, S., Mäkinen, P. M., Kemppainen, S., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01384.x · Cited by 72 · see citing works

The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse

Schechter, R., Beju, D., & Miller, K. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.001 · Cited by 61 · see citing works

Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model

Ponce-López, T., Liy-Salmerón, G., Hong, E., & Meneses, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.09.056 · Cited by 59 · see citing works

Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies

Vignini, A., Giulietti, A., Nanetti, L., Raffaelli, F., Giusti, L., Mazzanti, L., & Provinciali, L. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309030003 · Cited by 57 · see citing works

Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications

Deutsch, S. I., Rosse, R. B., & Lakshman, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.007 · Cited by 56 · see citing works

Geniposide Attenuates Mitochondrial Dysfunction and Memory Deficits in APP/PS1 Transgenic Mice

Lv, C., Liu, X., Liu, H., Chen, T., & Zhang, W. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140618095925 · Cited by 49 · see citing works

Inhibition of staurosporine-induced neuronal cell death by bisphenol A and nonylphenol in primary cultured rat hippocampal and cortical neurons

Negishi, T., Ishii, Y., Kyuwa, S., Kuroda, Y., & Yoshikawa, Y. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.031 · Cited by 42 · see citing works

Progress in the development of new drugs in Alzheimer's disease

Piau, A., Nourhashémi, F., Hein, C., Caillaud, C., & Vellas, B. J. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0012-x · Cited by 41 · see citing works

Geniposide Attenuates Oligomeric Aβ1-42-Induced Inflammatory Response by Targeting RAGE-Dependent Signaling in BV2 Cells

Lv, C., Wang, L., Liu, X., Cong, X., Yan, S. S., Wang, Y., & Zhang, W. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140514111204 · Cited by 34 · see citing works

Geniposide decreases the level of Aβ1−42 in the hippocampus of streptozotocin-induced diabetic rats

Liu, J., Zhang, Y., Deng, X., & Yin, F. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt069 · Cited by 32 · see citing works

Geniposide Regulates Insulin-Degrading Enzyme Expression to Inhibit the Cytotoxicity of Aβ1-42 in Cortical Neurons

Yin, F., Zhang, Y., Guo, L., Kong, S., & Liu, J. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311211080015 · Cited by 28 · see citing works

Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies

Dai, Y., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660134 · Cited by 26 · see citing works

The Role of Neurotrophins and Insulin on Tau Pathology in Alzheimer's Disease

Elliott, E., & Ginzburg, I. (2006) · Reviews in the Neurosciences · doi:10.1515/revneuro.2006.17.6.635 · Cited by 23 · see citing works

Modelling Alzheimer‐specific abnormal Tau phosphorylation independently of GSK3β and PKA kinase activities

Delobel, P., Flament, S., Hamdane, M., Delacourte, A., Vilain, J., & Buée, L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02525-5 · Cited by 22 · see citing works

Insulin resistance: an emerging link in Alzheimer’s disease

Medhi, B., & Chakrabarty, M. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1454-1 · Cited by 21 · see citing works

Overcoming Cell Death and Tau Phosphorylation Mediated by PI3KInhibition: A Cell Assay to Measure Neuroprotection

Simón, D., Medina, M., Ávila, J., & Wandosell, F. G. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480401 · Cited by 16 · see citing works

Alzheimer’s disease risk, obesity and tau: is insulin resistance guilty?

Blum, D. L., & Buée, L. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.35 · Cited by 8 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease

Walker, J. M., Dixit, S., Saulsberry, A. C., May, J. M., & Harrison, F. E. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.01.004 · Cited by 110 · see citing works

Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight

Habtemariam, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010004 · Cited by 100 · see citing works

Diverse Pharmacological Activities and Potential Medicinal Benefits of Geniposide

Zhou, Y., Zhang, R., Rahman, K., Cao, Z., Zhang, H., & Peng, C. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/4925682 · Cited by 97 · see citing works

GSK3: A potential target and pending issues for treatment of Alzheimer's disease

Zhao, J., Wei, M., Guo, M., Wang, M., Niu, H., Xu, T., & Zhou, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14818 · Cited by 97 · see citing works

High fat diet worsens Alzheimer’s disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow.

Bracko, O., Vinarcsik, L. K., Cruz Hernández, J. C., Ruiz-Uribe, N. E., Haft-Javaherian, M., Falkenhain, K., Ramanauskaite, E. M., Ali, M., Mohapatra, A., Swallow, M. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65908-y · Cited by 85 · see citing works

Properties and molecular mechanisms underlying geniposide-mediated therapeutic effects in chronic inflammatory diseases

Deng, R., Wu, H., Yan, W., & Mengdie, W. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113958 · Cited by 69 · see citing works

Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice

Zhou, Z., Hou, J., Mo, Y., Ren, M., Yang, G., Qu, Z., & Hu, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172857 · Cited by 66 · see citing works

Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism

Wang, Y., Hu, H., Liu, X., & Guo, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1138499 · Cited by 67 · see citing works

Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects

Habtemariam, S. (2018) · Molecules · doi:10.3390/molecules23010117 · Cited by 55 · see citing works

The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease

Huang, C., Chu, H., Ma, Y., Zhou, Z., Dai, C., Huang, X., Fang, L., Ao, Q., & Huang, D. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.08.015 · Cited by 50 · see citing works

The emerging possibility of the use of geniposide in the treatment of cerebral diseases: a review

Zhang, W., Zhang, F., Hu, Q., Xiao, X., Ou, L., Chen, Y., Luo, S., Cheng, Y., Jiang, Y., Ma, X., et al. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00486-3 · Cited by 46 · see citing works

Geniposide Improves Glucose Homeostasis via Regulating FoxO1/PDK4 in Skeletal Muscle

Yan, L., Pan, H., Zhang, X., Wang, H., Liu, S., Zhang, H., Qian, H., Wang, L., & Ying, H. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00402 · Cited by 36 · see citing works

Diosgenin and 5‐Methoxypsoralen Ameliorate Insulin Resistance through ER‐α/PI3K/Akt‐Signaling Pathways in HepG2 Cells

Fang, K., Dong, H., Jiang, S., Li, F., Wang, D., Yang, D., Gong, J., Huang, W., & Lu, F. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7493694 · Cited by 36 · see citing works

Genipin Attenuates Tau Phosphorylation and Aβ Levels in Cellular Models of Alzheimer’s Disease

Li, M., Cai, N., Gu, L., Yao, L., Bi, D., Fang, W., Lin, Z., Wu, Y. L., Xu, H. Y., Li, H., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02389-8 · Cited by 33 · see citing works

Research and application progress of Gardenia jasminoides

Yin, F., & Liu, J. (2018) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2018.09.001 · Cited by 31 · see citing works

Therapeutic Potential and Effective Components of the Chinese Herb Gardeniae Fructus in the Treatment of Senile Disease

Lv, S., Ding, Y., Zhao, H., Liu, S., Zhang, J., & Wang, J. (2018) · Aging and Disease · doi:10.14336/ad.2018.0112 · Cited by 30 · see citing works

Effect of natural products on diabetes associated neurological disorders

Patel, S. S., & Malairaman, U. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0038 · Cited by 28 · see citing works

Neuropharmacological insights into Gardenia jasminoides Ellis: Harnessing therapeutic potential for central nervous system disorders

Hou, Z., Sun, L., Jiang, Z., Zeng, T., Wu, P., Huang, J., Liu, H., & Xiao, P. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155374 · Cited by 27 · see citing works

Geniposide attenuates epilepsy symptoms in a mouse model through the PI3K/Akt/GSK‑3β signaling pathway

Wei, H., Duan, G., He, J., Meng, Q., Liu, Y., Chen, W., & Meng, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5512 · Cited by 27 · see citing works

High fat diet worsens pathology and impairment in an Alzheimer’s mouse model, but not by synergistically decreasing cerebral blood flowPreprint

Bracko, O., Vinarcsik, L., Hernández, J. C. C., Ruiz‐Uribe, N. E., Haft‐Javaherian, M., Falkenhain, K., Ramanauskaitė, E. M., Ali, M. A., Mohapatra, A., Swallow, M. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.16.878397 · Cited by 23 · see citing works

Geniposide Attenuates the Level of Aβ1-42 via Enhancing Leptin Signaling in Cellular and APP/PS1 Transgenic Mice

Liu, Z., Zhang, Y., Liu, J., & Yin, F. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0875-9 · Cited by 21 · see citing works

Geniposide Increases Unfolded Protein Response-Mediating HRD1 Expression to Accelerate APP Degradation in Primary Cortical Neurons

Cui, H., Deng, M., Zhang, Y., Yin, F., & Liu, J. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2469-z · Cited by 17 · see citing works

Drugs for Targeted Therapies of Alzheimer’s Disease

Tam, C., Wong, J. H., Ng, T. B., Tsui, S. K., & Zuo, T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180430150940 · Cited by 15 · see citing works

High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice

Gong, X., Liang, Z., Liu, W. D., Zhao, Y., Yang, Y., Wu, M., Shang, J., Xiao, Y., Mei, Y., Su, Q., et al. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210628100812 · Cited by 14 · see citing works

Genipin and pyrogallol: Two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease

Kim, S., Hyun, D. G., Nam, Y., Shin, S. J., Im, D., Kim, H. S., Leem, S. H., Park, H. H., Kim, B., Park, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115770 · Cited by 12 · see citing works

A network pharmacology approach to reveal the key ingredients in Scrophulariae Radix (SR) and their effects against Alzheimer's disease

Shi, Y., Chen, Z., Huang, L., Gong, Y., & Shi, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24785 · Cited by 10 · see citing works

The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients

Zhang, Y., Liao, X., Xu, J., Yin, J., Li, S., Li, M., Shi, X., Zhang, S., Li, C., Xu, W., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12122783 · Cited by 7 · see citing works

Neurotrophic Natural Products

Fukuyama, Y., Kubo, M., & Harada, K. (2024) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-031-42422-9_1 · Cited by 7 · see citing works

Pharmacology of Iridoids

Dinda, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-05575-2_5 · Cited by 6 · see citing works

Therapeutic potential of natural products against Alzheimer's disease via autophagic removal of Aβ

Hu, M., Ying, X., Zheng, M., Wang, C., Li, Q., Gu, L., & Zhang, X. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110835 · Cited by 5 · see citing works

Traditional Chinese Medicine Natural Products Targeting Shared Mechanisms of T2DM and AD: Potential Therapeutic Insights

Song, B., Yue, D., Yan, H., Feng, L., & Li, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s531909 · Cited by 2 · see citing works

Potential Drug Interventions on Formaldehyde-Induced Neuronal Toxicity

Zhang, Z., Hua, Q., & He, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-7281-3_18 · Cited by 1 · see citing works

Interruption of the Gut Integrity Contributes to Early Accumulation of Amyloid-β in the Enteric Nervous System in Rats Supplemented with a High-Fat Diet

Gawish, Z., Gamal, M., Elberry, D. A., Hegazy, E., Rashed, L. A., Hosny, S. A., Mehesen, M. N., & ShamsEldeen, A. M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05261-1

Geniposide Attenuates Insulin-Deficiency-Induced Acceleration of β-amyloidosis in an APP/PS1 Transgenic Model of Alzheimer's Disease

Zhang, Y., Yin, F., Liu, J., Liu, Z., Guo, L., Xia, Z., & Zidichouski, J. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.04.002 · Cited by 45 · see citing works

Leptin Signaling Plays a Critical Role in the Geniposide-Induced Decrease of Tau Phosphorylation

Liu, J., Liu, Z., Zhang, Y., & Yin, F. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv106 · Cited by 11 · see citing works

Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology

Gratuze, M., Julien, J., Petry, F. R., Morin, F., & Planel, E. (2017) · Scientific Reports · doi:10.1038/srep46359 · Cited by 66 · see citing works

Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK 3β Pathway in Streptozotocin‐Induced A lzheimer Rat Model

Gao, C., Liu, Y., Jiang, Y., Ding, J., & Li, L. (2013) · Brain Pathology · doi:10.1111/bpa.12116 · Cited by 141 · see citing works

Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency

Clodfelder‐Miller, B., Zmijewska, A. A., Johnson, G. V. W., & Jope, R. S. (2006) · Diabetes · doi:10.2337/db06-0485 · Cited by 185 · see citing works